Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of mouse lung tissue from amiodarone and/or dabigatran treated animals

ABSTRACT: RNA-seq of mouse lung tissue from amiodarone and/or dabigatran treated animals

PROVIDER: PRJNA681156 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13155534.fastq.gz	Fastqsanger.gz
	SRR13155535.fastq.gz	Fastqsanger.gz
	SRR13155536.fastq.gz	Fastqsanger.gz
	SRR13155537.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

RNA-seq of mouse lung tissue from amiodarone and/or dabigatran treated animals

Project description:Interstitial lung disease (ILD) is a group of respiratory disorders characterized by chronic inflammation and fibrosis of the pulmonary interstitial tissues. Although the etiology of ILD remains unclear, some drug treatments are one of the primary causes of ILD. In the present study, we analyzed FDA Adverse Event Reporting System and JMDC insurance claims to find a coexisting drug that reduced the incidence of ILD associated with use of an anti-arrhythmic agent, amiodarone, and found that the thrombin inhibitor dabigatran prevented the amiodarone-induced ILD in both clinical datasets. In an experimental validation of the hypothesis, a long-term, oral treatment of mice with amiodarone caused a gradual decrease in the body weight caused by respiratory insufficiency. In the lung of amiodarone-treated mice, infiltration of macrophages and interstitial thickening were observed in parallel with a delayed upregulation of platelet-derived growth factor receptor α gene. In contrast, co-treatment with dabigatran significantly attenuated these amiodarone-induced changes representing ILD. These results suggest that dabigatran is effective in preventing the drug-induced ILD. This combinatorial approach of drug repositioning based on clinical big data will pave the way for finding a new treatment with high clinical predictability and a well-defined molecular mechanism.

2020-12-03 | GSE162229 | GEO

Human lung tissue treated with interferons

Project description:Human lung tissue treated with interferons

| PRJNA779735 | ENA

GNPS - Mouse Lung Tissue Extract

Project description:Small molecule extraction from mouse lung tissue analyzed by positive mode LC-MS/MS.

| MSV000080182 | GNPS

Human lung tissue treated with interferons

Project description:RNAseq analysis of human lung slices after treatment with different interferons. Results: Differentially expressed genes were observed after treatment with different interferons. Methods: Tumor-free human lung explants were obtained from patients undergoing lung surgery at the University Hospital Muenster on the day of surgery. Tissue blocks were individually placed in a 12-well plate in RPMI medium. Tissues were treated with different interferons. RNA was prepared from tissue homogenates.

2022-08-31 | GSE188637 | GEO

RNA-seq of rat Achilles tendon tissue from pefloxacin and/or dexamethasone treated animals

Project description:RNA-seq of rat Achilles tendon tissue from pefloxacin and/or dexamethasone treated animals

| PRJNA875088 | ENA

RNA-seq from animals treated, and non treated, with cisplatin

Project description:RNA-seq from animals treated, and non treated, with cisplatin

| PRJNA437671 | ENA

Mouse cardiac tissue: Vehicle treated control vs. 15mg/kg doxorubicin

Project description:Transcriptional profiling of mouse cardiac tissue treated with 15mg/kg doxorubicin in 10 ml/kg saline over an acute time course (0.5-120 hours) compared to time matched control animals treated with 10ml/kg saline.

2010-08-06 | GSE17826 | GEO

Mouse cardiac tissue: Vehicle treated control vs. 25mg/kg DMNQ

Project description:Transcriptional profiling of mouse cardiac tissue treated with 25mg/kg DMNQ in 10 ml/kg arachis oil over an acute time course (5 minutes-120 hours) compared to time matached control animals treated with 10ml/kg arachis oil

2010-08-06 | GSE17915 | GEO

lung tissue sample

Project description:lung tissue sample Raw sequence reads

| PRJNA747828 | ENA

Expression profiling of rat heart and blood after amiodarone treatment

Project description:In the present study, an oligonucleotide microarray platform was used to compare expression profiles of heart and blood in rats treated with amiodarone against respective controls. Male Sprague-Dawley (CD) rats, which were 10 weeks old and weighed 290-320 grams at the beginning of the study, have been treated for ten days with amiodarone by oral route at a dose of 300mg/Kg/die. The study has been constituted by a control group, which received the vehicle (methylcellulose 1%, w/v), and by a treatment group (10 animals for both groups). For each tissue sample, total RNA has been individually extracted and evaluated. For each tissue, three pools/group (2 pools composed of 3 animals and the last one by 4) have been used for microarray analysis. A modulation of 600 genes in heart and 8300 genes in blood has been obtained.

2015-03-23 | GSE24213 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data